Showing 102,781 - 102,800 results of 103,943 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( e ((nn decrease) OR (point decrease)) ))', query time: 1.41s Refine Results
  1. 102781
  2. 102782

    Evaluation of disparities in zinc coverage. by Keith Beam (20700854)

    Published 2025
    “…<div><p>Oral zinc is a proven effective treatment for diarrheal illness, and long-term monitoring is key to evaluating the success of efforts to scale up zinc treatment. …”
  3. 102783

    Table_1_Protective effect of zinc gluconate on intestinal mucosal barrier injury in antibiotics and LPS-induced mice.DOCX by Yongcai Wang (16523067)

    Published 2024
    “…</p>Methods<p>We established a composite mouse model by inducing intestinal mucosal barrier damage using antibiotics and LPS. …”
  4. 102784

    Table_11_Effect of Enteral Immunonutrition in Patients Undergoing Surgery for Gastrointestinal Cancer: An Updated Systematic Review and Meta-Analysis.doc by Jingyi Shen (2464609)

    Published 2022
    “…Compared with the control group, EIN group had a significantly decreased incidence of overall complications (RR = 0.79, p < 0.001). …”
  5. 102785

    Data_Sheet_1_Effect of Enteral Immunonutrition in Patients Undergoing Surgery for Gastrointestinal Cancer: An Updated Systematic Review and Meta-Analysis.DOC by Jingyi Shen (2464609)

    Published 2022
    “…Compared with the control group, EIN group had a significantly decreased incidence of overall complications (RR = 0.79, p < 0.001). …”
  6. 102786
  7. 102787

    Image_1_Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution.TIF by Xianxiong Ma (4276441)

    Published 2021
    “…Moreover, C2 was associated with a lower tumor mutation burden, a decreased neoantigen load, and fewer CNVs. …”
  8. 102788

    Image_12_Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution.TIF by Xianxiong Ma (4276441)

    Published 2021
    “…Moreover, C2 was associated with a lower tumor mutation burden, a decreased neoantigen load, and fewer CNVs. …”
  9. 102789
  10. 102790
  11. 102791

    Table_6_Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution.XLSX by Xianxiong Ma (4276441)

    Published 2021
    “…Moreover, C2 was associated with a lower tumor mutation burden, a decreased neoantigen load, and fewer CNVs. …”
  12. 102792

    An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2 by Chung-Tao Tang (764646)

    Published 2015
    “…<div><p>Dengue virus (DENV), a global disease, is divided into four serotypes (DENV1-4). …”
  13. 102793
  14. 102794
  15. 102795
  16. 102796

    Table_9_Effect of Enteral Immunonutrition in Patients Undergoing Surgery for Gastrointestinal Cancer: An Updated Systematic Review and Meta-Analysis.doc by Jingyi Shen (2464609)

    Published 2022
    “…Compared with the control group, EIN group had a significantly decreased incidence of overall complications (RR = 0.79, p < 0.001). …”
  17. 102797

    Image_4_Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution.TIF by Xianxiong Ma (4276441)

    Published 2021
    “…Moreover, C2 was associated with a lower tumor mutation burden, a decreased neoantigen load, and fewer CNVs. …”
  18. 102798

    Table_8_Effect of Enteral Immunonutrition in Patients Undergoing Surgery for Gastrointestinal Cancer: An Updated Systematic Review and Meta-Analysis.doc by Jingyi Shen (2464609)

    Published 2022
    “…Compared with the control group, EIN group had a significantly decreased incidence of overall complications (RR = 0.79, p < 0.001). …”
  19. 102799
  20. 102800

    Image_13_Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution.TIF by Xianxiong Ma (4276441)

    Published 2021
    “…Moreover, C2 was associated with a lower tumor mutation burden, a decreased neoantigen load, and fewer CNVs. …”